FABP1 and metabolic dysfunction-associated steatohepatitis: Nevertheless, the increased expression level of the Pparα–Fabp1 axis was always found in DIO mice, and the suppression of the Pparα–Fabp1 axis was considered as a treatment for nonalcoholic steatohepatitis [30], suggesting the potential threat of a high-BCAA diet.